Treatment options for polycystic ovary syndrome
- PMID: 21339935
- PMCID: PMC3039006
- DOI: 10.2147/IJWH.S11304
Treatment options for polycystic ovary syndrome
Abstract
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women. The clinical manifestation of PCOS varies from a mild menstrual disorder to severe disturbance of reproductive and metabolic functions. Management of women with PCOS depends on the symptoms. These could be ovulatory dysfunction-related infertility, menstrual disorders, or androgen-related symptoms. Weight loss improves the endocrine profile and increases the likelihood of ovulation and pregnancy. Normalization of menstrual cycles and ovulation could occur with modest weight loss as little as 5% of the initial weight. The treatment of obesity includes modifications in lifestyle (diet and exercise) and medical and surgical treatment. In PCOS, anovulation relates to low follicle-stimulating hormone concentrations and the arrest of antral follicle growth in the final stages of maturation. This can be treated with medications such as clomiphene citrate, tamoxifen, aromatase inhibitors, metformin, glucocorticoids, or gonadotropins or surgically by laparoscopic ovarian drilling. In vitro fertilization will remain the last option to achieve pregnancy when others fail. Chronic anovulation over a long period of time is also associated with an increased risk of endometrial hyperplasia and carcinoma, which should be seriously investigated and treated. There are androgenic symptoms that will vary from patient to patient, such as hirsutism, acne, and/or alopecia. These are troublesome presentations to the patients and require adequate treatment. Alternative medicine has been emerging as one of the commonly practiced medicines for different health problems, including PCOS. This review underlines the contribution to the treatment of different symptoms.
Keywords: polycystic ovary syndrome; treatment.
Similar articles
-
Polycystic Ovary Syndrome: A Literature Review With a Focus on Diagnosis, Pathophysiology, and Management.Cureus. 2023 Oct 20;15(10):e47408. doi: 10.7759/cureus.47408. eCollection 2023 Oct. Cureus. 2023. PMID: 38021970 Free PMC article. Review.
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC. Endocr Pract. 2015. PMID: 26509855
-
Molecular Mechanisms of Laparoscopic Ovarian Drilling and Its Therapeutic Effects in Polycystic Ovary Syndrome.Int J Mol Sci. 2020 Oct 31;21(21):8147. doi: 10.3390/ijms21218147. Int J Mol Sci. 2020. PMID: 33142702 Free PMC article. Review.
-
Ovulation induction in polycystic ovary syndrome.J Obstet Gynaecol Can. 2010 May;32(5):495-502. doi: 10.1016/S1701-2163(16)34504-2. J Obstet Gynaecol Can. 2010. PMID: 20500959
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.Endocr Pract. 2015 Dec;21(12):1415-26. doi: 10.4158/EP15748.DSCPT2. Endocr Pract. 2015. PMID: 26642102 Review.
Cited by
-
Acupuncture combined with metformin versus metformin alone to improve pregnancy rate in polycystic ovary syndrome: A systematic review and meta-analysis.Front Endocrinol (Lausanne). 2022 Aug 29;13:978280. doi: 10.3389/fendo.2022.978280. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36105396 Free PMC article.
-
Polycystic Ovary Syndrome: A Literature Review With a Focus on Diagnosis, Pathophysiology, and Management.Cureus. 2023 Oct 20;15(10):e47408. doi: 10.7759/cureus.47408. eCollection 2023 Oct. Cureus. 2023. PMID: 38021970 Free PMC article. Review.
-
Diagnosis and management of polycystic ovary syndrome in the UK (2004-2014): a retrospective cohort study.BMJ Open. 2016 Jul 11;6(7):e012461. doi: 10.1136/bmjopen-2016-012461. BMJ Open. 2016. PMID: 27401369 Free PMC article.
-
Metformin versus chromium picolinate in clomiphene citrate-resistant patients with PCOs: A double-blind randomized clinical trial.Iran J Reprod Med. 2013 Aug;11(8):611-8. Iran J Reprod Med. 2013. PMID: 24639797 Free PMC article.
-
Exercise-induced irisin improves follicular dysfunction by inhibiting IRE1α-TXNIP/ROS-NLRP3 pathway in PCOS.J Ovarian Res. 2023 Jul 31;16(1):151. doi: 10.1186/s13048-023-01242-x. J Ovarian Res. 2023. PMID: 37525261 Free PMC article.
References
-
- Speroff L, Fritz MA. Anovulation and the polycystic ovary. In: Speroff L, Fritz MA, editors. Clinical Gynecologic Endocrinology and Infertility. 7th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2005. pp. 470–483.
-
- Azziz R. Diagnostic criteria for polycystic ovary syndrome: a reappraisal. Fertil Steril. 2005;83(5):1343–1346. - PubMed
-
- Lakhani K, Prelevic GM, Seifalian AM, Atiomo WU, Hardiman P. Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factors. J Obstet Gynaecol. 2004;24(6):613–621. - PubMed
-
- Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352(12):1223–1236. - PubMed
-
- Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18(6):774–800. - PubMed
LinkOut - more resources
Full Text Sources
Medical